[1]
|
Virgolini I,Leimer M,Handmaker,et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer,99Tcm-P829[J]. Cancer Res,1998,58(9):18501859. |
[2]
|
Decristoforo C,Mather SJ. Preparation 99Tcm-labeling,and in vitro characterization of HYNIC and N3S modified RC-160 and[Tyr3] octreotide[J]. Bioconjug Chem,1999,10(3):431-438. |
[3]
|
Balon HR,Goldsmith SJ,Siegel BA,et al. Procedure guideline for somatostatin receptor scintigraphy with 111In-Pente-treotide[J]. J Nucl Med,2001,42(7):1134-1138. |
[4]
|
Vaccarili M,Lococo A,Fabiani F,et al. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer[J]. Tumori, 2000, 86(3):224-228. |
[5]
|
Reisinger I,Bohuslavitzki KH,Brenner W,et al. Somatostatin receptor scintigraphy in small-cell lung cancer:results of a multicenter study[J]. J Nucl Med,1998,39(2):224-227. |
[6]
|
Pearson DA, Lister-James J, Mcbride WJ, et al. Somatostatin receptor-binding peptides labeled with technetium-99m:chemistry and initial biological studies[J]. J Med Chem,1996,39:1361-1371. |
[7]
|
Uehara T,Arano Y,Ono M,et al. The integrity of the disulfide bond in a cyclic somatostatin analog during 99Tcm complexion reactions[J]. Nucl Med Biol,1999,26(8):883-890. |
[8]
|
Pervez S,Mushtaq AM,Arif M. Technetium-99m direct radiolabeling of lanreotide:a somatostatin analog[J]. Appl Ra-diat Isot,2001,55(5):647-651. |
[9]
|
Kwekkeboom D, krenning E, Bakker W. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer[J].J Nucl Med,1991,32:1845-1848. |
[10]
|
Bombardieri E,Chiti A,Crippa F,et al. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer[J]. Q J Nucl Med,1995,39(4 suppl 1):104-107. |
[11]
|
Bohuslavizki KH. Somatostatin receptor imaging:current status and future perspectives[J]. J Nucl Med,2001,42(7):1057-1058. |